Skip to content
The Journal

Weight, honestly/Compounds

The Holiday Pound Is Small. It Just Never Leaves.

The famous five-pound holiday gain is a myth. The real number is smaller, and that's the problem. Here's what a holiday trial says works, and what your gut's own fullness peptides have to do with it.

Human clinical trialEarly human researchRegulatory context3 min

Inspired Labs Editorial/Nov 1, 2026/7 sources

The Holiday Pound Is Small. It Just Never Leaves.

Thanksgiving is three and a half weeks out. Somebody at work has already said "well, there goes five pounds," and everyone nodded like it's a law of physics.

Good news: it isn't five. Less-good news: what it actually is tends to stick around.

Do people really gain five pounds over the holidays?

No. In 2000, NIH researchers weighed about 200 adults from fall through the following spring.

The average gain from mid-November to early January was under a pound. Not exactly a headline.

The catch is what happened next. Spring and summer didn't take it back. A year later, it was still there.

That study was observational, and the people in it were mostly NIH employees, not a random slice of America. But the idea is useful: the holidays don't wreck you. They add a small, quiet pound that moves in for good.

So what actually helps?

A team at the University of Birmingham tested this directly. In 2016 and 2017, they randomly split about 270 adults before Christmas.

One group got a leaflet about healthy living. The other group got three things:

Step on the scale often. They were asked to weigh themselves at least twice a week and write it down. Not to panic. Just to notice.

Know what a treat "costs" in walking. They got pictures translating festive foods into minutes of activity. Picture a slice of pie labeled with how long you'd have to walk to burn it off.

Have a few holiday game plans. Simple tips for parties, portions and drinks.

By January, the leaflet group had gained a bit. The scale-and-walking group hadn't. The difference was about a pound, which is pretty much the holiday pound itself.

Two habits from other research fit right in:

Slow down. More on why in a second.

Take a short walk after the big meal. A 2022 review of short lab studies found light walking after sitting helped blunt the blood-sugar spike after eating. Standing helped too, just less. Your uncle's after-dinner lap of the block is accidentally evidence-based.

The holidays don't add five pounds. They add one quiet pound that never moves out.

Why would eating slowly matter?

Because your gut sends "I'm full" on a delay, and it speaks in peptides.

When food hits your intestines, special cells release little protein messengers. Two big ones are GLP-1 and PYY. They tell your brain to wind down the fork.

In a small Greek study, 17 men ate the same big bowl of ice cream twice: once in 5 minutes, once over 30. The slow bowl produced noticeably more GLP-1 and PYY. People also felt a bit fuller, though that part was only a trend.

Small study, all men, one dessert. Still, it's a nice picture: you're giving the messenger time to arrive before you've cleaned the plate.

Where do the weight-loss drugs come in?

GLP-1 is the hormone the Ozempic family is built on. Your gut's version fades within minutes. Semaglutide, the drug in Ozempic and Wegovy, is engineered to keep that signal on all week.

Novo Nordisk, which makes it, ran a 72-person trial with a very holiday-friendly test: an all-you-can-eat lunch. After about 20 weeks, people on semaglutide ate roughly a third less at that buffet than people on placebo. They also reported fewer cravings.

That's a real randomized result, but it's small, Novo ran it, and it was done with doctors overseeing a prescription drug. Literature, not lore: what a supervised trial shows is not a reason to try anything at home.

The news keeps moving, too. On Oct 16, Europe's drug regulator recommended approving Foundayo, a once-a-day GLP-1 pill that's already on the US market. Fun twist: it isn't even a peptide. It's a small molecule that flips the same switch.

If you remember one thing…

The holiday pound is small, sneaky and preventable. Weigh in now and then, walk after the big meal, and eat slowly enough for your own fullness peptides to show up to dinner.

Everything Inspired Labs carries is for Research Use Only. It's lab material, not for your body, and nothing here is medical advice.

Sources

  1. 01A prospective study of holiday weight gain — Yanovski JA, Yanovski SZ, Sovik KN, Nguyen TT, O'Neil PM, Sebring NG (2000). N Engl J Med.

    Human-open (195-adult convenience sample; mean holiday-period gain 0.37 kg; net fall-to-spring gain 0.48 kg, not reversed by the following autumn in the 165 who returned).

  2. 02Effectiveness of a brief behavioural intervention to prevent weight gain over the Christmas holiday period: randomised controlled trial — Mason F, Farley A, Pallan M, Sitch A, Easter C, Daley AJ (2018). BMJ.

    Human-rct (272 adults, Birmingham UK, 2016–2017; self-weighing at least twice weekly, holiday weight-management tips, physical-activity calorie equivalents of festive foods; weight change −0.13 kg vs +0.37 kg leaflet comparator; adjusted difference −0.49 kg; follow-up 4–8 weeks).

  3. 03The acute effects of interrupting prolonged sitting time in adults with standing and light-intensity walking on biomarkers of cardiometabolic health in adults: a systematic review and meta-analysis — Buffey AJ, Herring MP, Langley CK, Donnelly AE, Carson BP (2022). Sports Med.

    Meta-analysis of seven one-day randomized crossover trials; light walking breaks lowered post-meal glucose and insulin vs continued sitting; standing lowered glucose less.

  4. 04Eating slowly increases the postprandial response of the anorexigenic gut hormones, peptide YY and glucagon-like peptide-1 — Kokkinos A, le Roux CW, Alexiadou K, et al (2010). J Clin Endocrinol Metab.

    Human crossover (17 healthy men; 300 ml ice cream in 5 vs 30 minutes; higher PYY and GLP-1 with the slow meal; fullness only a trend; no ghrelin difference).

  5. 05The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity — Friedrichsen M, Breitschaft A, Tadayon S, Wizert A, Skovgaard D (2021). Diabetes Obes Metab.

    Human-rct (72 adults with obesity, 20 weeks, double-blind vs placebo; ad libitum lunch energy intake 35% lower; fewer/weaker cravings on CoEQ; Novo Nordisk-sponsored, authors employees).

  6. 06New oral GLP-1 medicine for weight management and type 2 diabetes — European Medicines Agency (2026). European Medicines Agency (Oct 16, 2026).

    Regulatory (CHMP recommended EU marketing authorisation for Foundayo (orforglipron); EMA describes orforglipron as "a small, non-peptide molecule" that activates the GLP-1 receptor).

  7. 07Foundayo (orforglipron) tablets, film coated: label and listing — Eli Lilly and Company (2026). DailyMed (U.S. National Library of Medicine).

    Regulatory: FDA-approved under NDA 220934 (April 1, 2026); DailyMed lists the product as actively marketed in the U.S. since April 1, 2026.

Educational material for laboratory research context only. Nothing here is medical advice, a protocol for human use, or a claim that Inspired Labs products diagnose, treat, cure, or prevent disease.

Inspired Labs — Precision. Purity. Performance.